We are now in the process of making our hiPSC-derived retinal organoids commercially available as a product so you can perform assays in-house that will support your pre-clinical research and development. Throughout
Gene therapy has come of age after three decades of efforts in research and development and the approval of several gene therapy products by the US Food and Drug Agency (FDA) over
Newcells Biotech’s team has developed a state-of-the-art iPSC-derived in vitro model of the human upper airway to accelerate the development of novel treatments against Covid-19 and other respiratory infections. This model is the best-characterised near physiological in vitro model available to
At Newcells Biotech, we build our Industry leading scientific expertise and technical excellence into all the products and services we offer to our customers, delivering innovative solutions for drug development. Newcells’ flagship
Newcells Biotech and Takeda Pharmaceutical International Co. have collaborated in a study designed to assess drug safety. The study evaluated a set of 36 known drugs and 9 of Takeda’s internal candidate
Newcells Biotech is collaborating with industry leaders and expert academics in a European-wide interdisciplinary initiative to develop animal-free methods for drug safety evaluations. The initiative (the EU funded in3 project) is driven
There are few topics more controversial than the use of animals in science, despite the enormous contribution animal experimentation continues to make to the development of new medicines and surgical techniques. Animals
Newcastle-based human stem cell model specialists, Newcells Biotech, have secured a total of £5.25m worth of funding to accelerate their growth plans in the international life sciences market. The funding comes from
The kidney proximal tubule is of key interest in drug discovery. This is due to its primary role in the excretion and reabsorption of xenobiotics, such as drugs and carcinogens. Current primary
In line with our previous Covid-19 Action Plan, Newcells Biotech has continued to review and invest in measures to reduce the risk to its staff and our wider community from the Covid-19
The proximal tubule is key due to its role in the excretion and reabsorption of many xenobiotic compounds. Due to the high costs associated with drug discovery and the clinical demand for
Covid-19 is known to infect the lungs. However, the dynamics of viral infection and replication are poorly understood. Alongside the Liverpool School of Tropical Medicine, we have been working to develop a
